Hansoh Pharmaceutical (3692) 股票預測
AI 預測: 3692
AI 會發佈下一個交易日、週末及月底的目標價。變動幅度以最新價格為基準計算。這些均為統計估算,並非投資建議。
過去 6 個月價格
Premium 顯示此股票及其他所有股票嘅 AI 目標價:1 日、1 星期同 1 個月。
解鎖 Premium🔒 預測紀錄
預測紀錄 — 將過往預測與實際收市價對照 — 屬 Premium 功能。
解鎖 Premium關於呢間公司
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).